Series A Round

Resurrect Bio is a plant disease resistance startup focused on enhancing the immune systems of crops through proprietary gene editing technology. The company aims to revolutionize agriculture by improving crop resilience against diseases, utilizing advanced techniques such as FloraFold® AI computational biology and high-throughput screening. This funding will support the development of their innovative platform and accelerate their research efforts in crop biotechnology. The initial close of this Series A funding round was led by Corteva, a leader in agricultural sciences, highlighting the strategic importance of Resurrect Bio's technology in the future of sustainable agriculture. The funding will also enable collaborations with agricultural stakeholders to implement their solutions in real-world farming scenarios. The total amount raised in this initial close is $8.1 million, which will be pivotal in advancing multiple disease resistance products and enhancing their high-throughput trait discovery platform.